Kissow, Hannelouise <br/><br/>
Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.  [electronic resource] 

 -  Regulatory peptides  Nov 2012 
 - 91-100 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-1686 
<br/><br/><label>Standard No.: </label>10.1016/j.regpep.2012.08.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1,2-Dimethylhydrazine--administration & dosage<br/>Aberrant Crypt Foci--pathology<br/>Adenoma--chemically induced<br/>Anatomy, Cross-Sectional<br/>Animals<br/>COS Cells<br/>Chlorocebus aethiops<br/>Colon--drug effects<br/>Colonic Neoplasms--metabolism<br/>Cyclic AMP--metabolism<br/>Diabetes Mellitus, Type 2--metabolism<br/>Dipeptidyl Peptidase 4--blood<br/>Dipeptidyl-Peptidase IV Inhibitors--pharmacology<br/>Exenatide<br/>Female<br/>Glucagon-Like Peptide 1--analogs & derivatives<br/>Glucagon-Like Peptide-1 Receptor<br/>Glucagon-Like Peptide-2 Receptor<br/>Hypoglycemic Agents--pharmacology<br/>Intestinal Mucosa--drug effects<br/>Intestine, Small--drug effects<br/>Liraglutide<br/>Mice<br/>Mice, Inbred C57BL<br/>Organ Size<br/>Peptides--pharmacology<br/>Pyrazines--pharmacology<br/>Receptors, Glucagon--agonists<br/>Sitagliptin Phosphate<br/>Transfection<br/>Triazoles--pharmacology<br/>Venoms--pharmacology